BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2393299)

  • 1. The involvement of carnitine intermediates in peroxisomal fatty acid oxidation: a study with 2-bromofatty acids.
    Buechler KF; Lowenstein JM
    Arch Biochem Biophys; 1990 Sep; 281(2):233-8. PubMed ID: 2393299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisomal fatty acid oxidation and inhibitors of the mitochondrial carnitine palmitoyltransferase I in isolated rat hepatocytes.
    Skorin C; Necochea C; Johow V; Soto U; Grau AM; Bremer J; Leighton F
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):561-7. PubMed ID: 1736904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisomal beta-oxidation of branched chain fatty acids in rat liver. Evidence that carnitine palmitoyltransferase I prevents transport of branched chain fatty acids into mitochondria.
    Singh H; Beckman K; Poulos A
    J Biol Chem; 1994 Apr; 269(13):9514-20. PubMed ID: 8144536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inactivation of peroxisomal and cytosolic 3-ketothiolase IB by 2-chloro-6-phenylhexanoate in intact hepatocytes.
    Sephton GB; Lowenstein JM
    J Biol Chem; 1990 Jun; 265(16):9214-20. PubMed ID: 2345171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of pathways of extramitochondrial fatty acid oxidation and liver fatty acid-binding protein by long-chain monocarboxylic fatty acids in hepatocytes. Effect of inhibition of carnitine palmitoyltransferase I.
    Kaikaus RM; Sui Z; Lysenko N; Wu NY; Ortiz de Montellano PR; Ockner RK; Bass NM
    J Biol Chem; 1993 Dec; 268(36):26866-71. PubMed ID: 8262919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: comparison between peroxisomal and mitochondrial beta-oxidation of omega-phenyl fatty acids in rat liver.
    Yamada J; Ogawa S; Horie S; Watanabe T; Suga T
    Biochim Biophys Acta; 1987 Sep; 921(2):292-301. PubMed ID: 3651489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of carnitine acyltransferase activity in mitochondria from rat and mouse liver by a diethylhexylphthalate metabolite.
    Grolier P; Elcombe CR
    Biochem Pharmacol; 1993 Feb; 45(4):827-32. PubMed ID: 8452557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
    Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
    Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of carnitine acyltransferases in peroxisomal fatty acid metabolism by the yeast Pichia guilliermondii.
    Pagot Y; Belin JM
    Appl Environ Microbiol; 1996 Oct; 62(10):3864-7. PubMed ID: 8837442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of peroxisomal proliferation by carnitine palmitoyltransferase inhibitors in cultured rat hepatocytes and in vivo.
    Hertz R; Bar-Tana J
    Biochem J; 1987 Jul; 245(2):387-92. PubMed ID: 3663164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of mitochondrial fatty acid oxidation by 2-bromopalmitate and its coenzyme A and carnitine esters.
    Chase JF; Tubbs PK
    Biochem J; 1972 Aug; 129(1):55-65. PubMed ID: 4646779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid oxidation in hepatic peroxisomes and mitochondria after treatment of rats with di(2-ethylhexyl)phthalate.
    Ganning AE; Olsson MJ; Peterson E; Dallner G
    Pharmacol Toxicol; 1989 Oct; 65(4):265-8. PubMed ID: 2587508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of fatty acid oxidation by 2-bromooctanoate. Evidence for the enzymatic formation of 2-bromo-3-ketooctanoyl coenzyme A and the inhibition of 3-ketothiolase.
    Raaka BM; Lowenstein JM
    J Biol Chem; 1979 Jul; 254(14):6755-62. PubMed ID: 447747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenone.
    Foxworthy PS; Eacho PI
    Biochem J; 1988 Jun; 252(2):409-14. PubMed ID: 3415664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-carnitine acyltransferase in intact peroxisomes is inhibited by malonyl-CoA.
    Derrick JP; Ramsay RR
    Biochem J; 1989 Sep; 262(3):801-6. PubMed ID: 2590167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats.
    Mannaerts GP; Debeer LJ; Thomas J; De Schepper PJ
    J Biol Chem; 1979 Jun; 254(11):4585-95. PubMed ID: 438207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the transport of acetyl groups from peroxisomes to mitochondria in isolated liver cells oxidizing the polyunsaturated fatty acid 22:4n-6.
    Tran TN; Christophersen BO
    Biochim Biophys Acta; 2001 Oct; 1533(3):255-65. PubMed ID: 11731335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkylthio acetic acids (3-thia fatty acids)--a new group of non-beta-oxidizable peroxisome-inducing fatty acid analogues--II. Dose-response studies on hepatic peroxisomal- and mitochondrial changes and long-chain fatty acid metabolizing enzymes in rats.
    Berge RK; Aarsland A; Kryvi H; Bremer J; Aarsaether N
    Biochem Pharmacol; 1989 Nov; 38(22):3969-79. PubMed ID: 2574577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid beta-oxidation in peroxisomes and mitochondria: the first, unequivocal evidence for the involvement of carnitine in shuttling propionyl-CoA from peroxisomes to mitochondria.
    Jakobs BS; Wanders RJ
    Biochem Biophys Res Commun; 1995 Aug; 213(3):1035-41. PubMed ID: 7654220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4.
    Violante S; Achetib N; van Roermund CWT; Hagen J; Dodatko T; Vaz FM; Waterham HR; Chen H; Baes M; Yu C; Argmann CA; Houten SM
    FASEB J; 2019 Mar; 33(3):4355-4364. PubMed ID: 30540494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.